Syncom Formulations | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
38
53
68
57
65
Total Accounts Receivable
488
394
441
550
570
Inventories
61
99
109
155
100
Other Current Assets
32
235
217
154
129
Total Current Assets
619
781
836
916
864
Net Property, Plant & Equipment
504
502
457
505
571
Total Investments and Advances
67
93
64
234
359
Intangible Assets
1
1
1
1
1
Other Assets
54
60
68
152
44
Total Assets
1,246
1,438
1,427
1,809
1,842
ST Debt & Current Portion LT Debt
21
33
61
56
125
Accounts Payable
194
294
199
469
323
Income Tax Payable
23
43
54
53
38
Other Current Liabilities
47
47
53
79
103
Total Current Liabilities
285
416
367
657
588
Deferred Taxes
61
67
55
58
72
Other Liabilities
22
1
2
4
6
Total Liabilities
369
486
424
722
668
Common Equity (Total)
876
951
1,001
1,086
1,173
Total Shareholders' Equity
876
951
1,001
1,086
1,173
Total Equity
876
951
1,001
1,086
1,173
Liabilities & Shareholders' Equity
1,246
1,438
1,427
1,809
1,842
Non-Equity Reserves
1
1
1
1
1

About Syncom Formulations

View Profile
Address
207, Saket Nagar
Indore Madhya Pradesh 452018
India
Employees -
Website http://www.syncomformulations.com
Updated 09/14/2018
Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company operates through the following segments: Pharmaceutical Drugs and Formulations, Trading of Commodities, and Renting of Property. Its products include tablets, ointment, liquid oral, capsules, and injections.